FDA Investigator Matthew C Watson

Matthew C Watson has conducted inspections on 218 sites in 13 countries as of 21 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
218
Last Inspection Date:
21 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
France, United States of America, Germany, India, Canada, Hong Kong, Poland, Switzerland, Romania, Czechia, Hungary, Mexico, United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Matthew C Watson:
Abby E Pelletier, Aireen V Mendoza, Alan R Condon, Alanna L Mussawwir Bias, Alice C Silva, Alicia A Dalley, Allen F Hall, Althea A Williams, Amanda E Lewin, PhD, Amber G Wardwell, Amy C Jordan, Andrew M Barlow, Ann L Demarco, Anthony C Warchut, Anthony E Keller, RPh, Anthony N Onianwa, Anthony W Thomas, Arie C Menachem, Arindam Dasgupta, PhD, Asia D Clark, Aurora Miha Trifanov, Barbara D Wright, Barbara M Frazier, Bo Chi, PhD, Bradford L Swanson, Brandy D Brown, Brenda P King, Brian L Belz, Byungja E Marciante, Camerson E Moore, Cara M Minelli, Carla C Cummins, Carla C Tuite, Carlos Chavez, Carmen Y Fisher, Charisse K Green, Charles A Snipes, PhD, Charles D Brown, Charles M Edwards, Charles R Bonapace, PhD, Charlotte Hinkle, Chiang Syin, PhD, Christine M Whitby, CSO, Christopher Janik, Chunsheng Cai, PhD, Constance Desimone, Courtney N Long, Craig A Garmendia, Cynthia F Kleppinger, MD, Cynthia Jim, CSO, Cynthia Whitmarsh, Daniel L Aisen, Darin S Wiegers, Daryl A Dewoskin, David P Vanhouten, Dawn C Olenjack, Dawn M Braswell, Deborah A Greco, Dell S Moller, Diane C Thibodeau, Diane M Biron, Diane M Prince, Dien N Nguyen, Djamila Harouaka, Dolores Harper, Dongping Dai, PhD, Donna J Clevenger, Dorothy W Lee, Dr. Abhijit Raha, PhD, Dr. Mark J Seaton, PhD, Dr. Robert C Horan, MD, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Edmund F Mrak, Jr, Edward J Janik, Eileen A Liu, Elizabeth B Griffin, Ellen P Madigan, Emily J Schramm, Eric C Schmitt, Farhana Khan, Francis A Guidry, Gabrielle J Swain, Gary J Hagan, Gene D Arcy, Geoffrey K Kilili, George T Allen, Jr, Gulshan R Anand, Hala L Selby, Hang N Guo, Hasan A Irier, PhD, Hector Jcolon Torres, Hugh M Mcclure, II, Iram R Hassan, PhD, James H Tanner, James P Finn, James P Mcevoy, James R Fleckenstein, James W Whitney, Jamie S Mathews, Jane M Kreis, Janete F Guardia, Jeffrey J Thibodeau, Jeffrey R Alling, Jennifer C Adams, Joanne E King, Joanne M Schlossin, John A Sciacchitano, John J Thibodeau, John L Zaccone, John P Mistler, John S Hartford, Jonah S Ufferfilge, Jonathan B Lewis, Jonathan G Matrisciano, Jose A Torres, Joshua D Levin, Joy P Matthias, Joyce A Kellett, Justin A Boyd, Justine M Corson, Ka L Wong, Kalkidan A Molla, Kara A Scheibner, PhD, Karen M Cooper, Karen Mcnabb Noon, Katherine D Adams, Katherine Szestypalow, Kathleen E Mcafoose, Kathryn A Krentz, Kenneth H Williams, Kent A Conforti, Kevin A Gonzalez, Kimberly A Benson, Kristina J Donohue, Kristy A Zielny, Kristy E Zuroski, Lauren Iacono Connors, PhD, Laurie B Frazier, Laurimer Kuilan Torres, LCDR Debra Emerson, Leo B Zadecky, Li Hongpaul Yeh, PhD, Li Yun Huang, Linda R Kuchenthal, Ling Yang, Lloyd D Payne, Lorayne A Mcguinness, Lori A Holmquist, Lori M Newman, Lucie Yang, Makini Cobourne Duval, PhD, Marc A Jackson, Jr, Marcia M Laughrey, Margaret M Sands, Marian E Ramirez, Mariza M Jafary, Mark R Mcclain, Marlene L Davis, Martin J Guardia, Mary Jeanet Mcgarry, Maya M Davis, Megan A Haggerty, Melkamu Getie Kebtie, PhD, Meredith L Miller, Miah Jung, Michael G Mayfield, Michael J Casey, Michael P Anthony, Michael P Sweeney, Michael R Goga, Michael Serrano, Michelle M Noe Varga, Mihaly S Ligmond, Min Lu, Minh D Phan, Mohsen Rajabi Abhari, FDA, Monica E Caphart, Nabil Nakhoul, Nealie C Newberger, Nichole B Murphy, Nicola M Fenty Stewart, Nina Yang, Paraluman S Leonin, Parul M Patel, Paul A Bonneau, Paul L Bellamy, Paul P Geraci, Peter R Lenahan, Philip Kreiter, Prabhu P Raju, Rachel M Skeete, Ramon E Martinez, Rapti D Madurawe, Rebecca T Davis, Richard A Abate, Richard B Mcaroy, Richard H Penta, Richard L Licari, Robert J Martin, Robert O'brian, Rory K Geyer, Ruben C Ayala, PharmD, S Lori Brown, PhD MPH, Sandra P White, Sandra S Saniga, Sara M Onyango, Sara M Richardson, Sarah E Mcmullen, Scott B Laufenberg, Seth A Mailhot, Sharon K Gershon, Sharon K Thoma, PharmD, Shirley S Wen, Simone E Pitts, Sripal R Mada, PhD, Stacey S Degarmo, Stephanie Mangigian, MS/OSH, RN, Stephen C Smith, Stephen R Souza, Steven M Weinman, Sunita Pandey, Susanne M Richardson, MS RAC, Suzanne M Healy, Terry C Kimball, Thomas J Arista, Thomas Siebertz, Thomas W Gordon, Tina A Desorcy, Torrance J Slayton, Tracey L Harris, Traci C Kelm, Truong Xuan Nguyen (Andy), Victor J Gangi, Victoria D'addeo, Victoria M Daddeo, Walden H Lee, Xikui Chen (nmi), PhD, Young M Choi, PhD, Yumi J Hiramine, Zachary A Bogorad, Ze Peng

Matthew C Watson's Documents

Publish Date Document Type Title
March, 2018 EIR Agios Pharmaceuticals, INC. - EIR, 2018-03-09
July, 2015 FDA 483 Jacob Laubach, M.D. - Form 483, 2015-07-21
May, 2022 FDA 483 Deepak C. D'Souza, M.D. - Form 483, 2022-05-20
August, 2019 EIR PAREXEL INTERNATIONAL, Corp - EIR, 2019-08-21
May, 2013 FDA 483 Sunovion Pharmaceuticals Inc. - Form 483, 2013-05-24
August, 2017 FDA 483 Claudia H. Arce Salinas, M.D. - Form 483, 2017-08-25
January, 2019 FDA 483 Cristina Cusin, M.D. - Form 483, 2019-01-15
February, 2020 EIR Karyopharm Therapeutics Inc. - EIR, 2020-02-28
November, 2023 FDA 483 VA Connecticut Health Care System IRB - Form 483, 2023-11-21
September, 2014 FDA 483 Pfizer Inc. Groton Laboratories - Form 483, 2014-09-30
June, 2014 FDA 483 Memorial Hospital of Rhode Island IRB - Form 483, 2014-06-10
December, 2014 EIR Pfizer Laboratories Div Pfizer Inc - EIR, 2014-12-05
June, 2021 EIR Sesen Bio, Inc. - EIR, 2021-06-03
February, 2016 EIR Boehringer Ingelheim Pharmaceuticals, Inc. - EIR, 2016-02-26
September, 2014 EIR Pfizer Inc. Groton Laboratories - EIR, 2014-09-30
July, 2017 FDA 483 Labcorp Bedford LLC. - Form 483, 2017-07-21
March, 2019 FDA 483 Lana M. Rifkin, M.D. - Form 483, 2019-03-12
April, 2017 FDA 483 TransMedics, Inc. - Form 483, 2017-04-26
December, 2020 FDA 483 Kadmon Corporation, LLC - Form 483, 2020-12-08
March, 2023 FDA 483 Glenn Gandelman, M.D. - Form 483, 2023-03-10
April, 2023 FDA 483 Elijah W. Stommel, M.D. - Form 483, 2023-05-19
July, 2016 EIR New England IRB - EIR, 2016-07-14
August, 2020 EIR Perceptive Informatics LLC (d.b.a. Calyx) - EIR, 2020-08-05
September, 2013 FDA 483 Labcorp Bedford LLC. - Form 483, 2013-09-20
June, 2014 EIR Robert L. Schlossman, M.D. - EIR, 2014-06-23
March, 2012 FDA 483 Charles Birbara, M.D. - Form 483, 2012-03-16
April, 2021 EIR Daniel J. DeAngelo, MD - EIR, 2021-04-16
June, 2014 EIR Memorial Hospital of Rhode Island IRB - EIR, 2014-06-10
February, 2018 FDA 483 James F. Markmann, MD - Form 483, 2018-02-15
February, 2020 FDA 483 Andrew A. Nierenberg, M.D. - Form 483, 2020-02-21
August, 2018 FDA 483 Response Aditya Bardia, M.D. - Form 483R, 2018-09-06
December, 2011 EIR Jenis, Louis G., M.D. - EIR, 2011-12-07
December, 2011 FDA 483 Response Jenis, Louis G., M.D. - Form 483R, 2011-12-21
August, 2018 FDA 483 Aditya Bardia, M.D. - Form 483, 2018-08-17
April, 2019 EIR Sarepta Therapeutics, Inc. - EIR, 2019-04-18
August, 2013 EIR Smithers ERS, LLC - EIR, 2013-08-23
August, 2011 FDA 483 TGA Sciences, Inc. - Form 483, 2011-08-31
December, 2011 FDA 483 Jenis, Louis G., M.D. - Form 483, 2011-12-07
June, 2019 FDA 483 Christopher J. Hartnick, MD - Form 483, 2019-06-28
December, 2020 EIR Kadmon Corporation, LLC - EIR, 2020-12-08
September, 2021 FDA 483 Jeffrey S. Dover, MD - Form 483, 2021-09-20
April, 2019 EIR AMAG Pharmaceuticals, Inc. - EIR, 2019-04-05
June, 2020 EIR Justin F. Gainor, M.D. - EIR, 2020-06-08

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more